IMvoke010: A Phase III, Double-Blind Randomized Trial of Atezolizumab (atezo) after Definitive Local Therapy Vs Placebo in Patients (pts) with High-Risk Locally Advanced (LA) Squamous Cell Carcinoma of the Head and Neck (SCCHN)
CANCER RESEARCH（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined